Duchenne/Becker muscular dystrophy carrier detection using quantitative PCR and fluorescence-based strategies

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Dystrophin gene deletions are a primary cause of Duchenne (DMD) and Becker (BMD) muscular dystrophies, accounting for up to 68% of mutations.
• Multiplex PCR is effective for detecting deletions in affected males and screening female carriers, but traditional methods have limitations.

Purpose of the Study:

• To develop and evaluate enhanced fluorescent labeling strategies for quantitative multiplex PCR.
• To improve the sensitivity and accuracy of detecting dystrophin gene deletions for carrier status determination.

Main Methods:

• Utilized two novel fluorescent labeling strategies: post-PCR staining with TOTO-1 and in-PCR incorporation of fluorescein-12,2'-dUTP.
• Employed a fluorescent fragment analyzer for quantitative dosage analysis of PCR products.
• Applied these methods to determine carrier status in 24 families with DMD/BMD.

Main Results:

• Both fluorescent methods demonstrated approximately 1,000-fold greater sensitivity than ethidium bromide staining.
• Successfully detected and quantified all multiplexed exons, including the challenging exon 48 fragment.
• Accurately determined DMD/BMD carrier status in the studied families.

Conclusions:

• Fluorochrome-labeled PCR products offer a sensitive and quantitative approach for multiplex PCR-based gene dosage analysis.
• These advanced methods facilitate reliable carrier status determination for DMD and BMD.
• The improved sensitivity aids in detecting difficult-to-quantify exon deletions, enhancing diagnostic capabilities.